The immunophenotype was characterized by positive Kappa, CD19, CD22, HLA-DR, and dim CD20 expressions and negative CD10, CD5, CD25, and CD33 expressions, consistent with CD5−CD10− mature B-cell lymphoma/leukemia. This evidence concerns the gene CD5 and B-cell non-Hodgkin lymphoma.